Animal studies have reported diminished cerebral CCK expression and the number of binding sites in the aging rat hippocampus (Harro and Oreland, 1992) and reduced hippocampal CCK mRNA levels in APP/PS1 mice, suggesting that a lack of CCK might predispose to neurodegeneration in AD (Liu et al., 2021). This evidence concerns the gene APP and Alzheimer disease.